Signed up for an internet plan that's left you stuck paying additional fees? Here's everything you need to know to find a ...
Hadush Kebatu is believed to have "access to funds" and to have sought assistance from members of the public both in London ...
NASP data highlight reduction in disease burden among people living with uncontrolled goutGamifant (emapalumab) data showed response rates in ...
UCB, a global biopharmaceutical company, today announced new three-year data from Phase 3 trials, and their open-label extensions, investigating BIMZELX® (bimekizumab-bkzx) in adults with active ...
Cardiff Oncology (CRDF) is a speculative buy with potential blockbuster gains ahead of its 2026 data readout. Read here for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results